REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biomedsa S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Other Chemical and Allied Products Merchant Wholesalers
Full name: Biomedsa S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Biomedsa S.A. is a company in Ecuador, with a head office in Manta. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on June 03, 2020. 6 (2021) employees currently work for Biomedsa S.A.. The latest financial highlights indicate a net sales revenue increase of 162.32% in 2022. Its’ total assets recorded a growth of 249.09%. In 2022, Biomedsa S.A.’s net profit margin decreased by 0.27%.

Headquarters
Avenida 4ta Oficina 40, Edificio Giler Bldg. , Floor 4
Manta; Manabi;

Contact Details: Purchase the Biomedsa S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Biomedsa S.A. report to view the information.
Outstanding Shares:
Purchase the Biomedsa S.A. report to view the information.
Registered Capital:
Purchase the Biomedsa S.A. report to view the information.
Incorporation Date:
June 03, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Biomedsa S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
162.32%▲
Total operating revenue
162.32%▲
Operating profit (EBIT)
155.86%▲
Net Profit (Loss) for the Period
155.86%▲
Total assets
249.09%▲
Total equity
19.82%▲
Operating Profit Margin (ROS)
-0.27%▼
Net Profit Margin
-0.27%▼
Return on Equity (ROE)
8.79%▲
Quick Ratio
-49.95%▼
Cash Ratio
-49.76%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo